Rigel Reports Third Quarter 2024 Financial Results and Provides Business Update
Go back to Rigel Reports Third Quarter 2024 Financial Results and Provides Business Update| Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) | Delayed: 46.82 -0.32 (0.68%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $47.14 | 52 Week High | $4.38 | |||
| Open | $46.82 | 52 Week Low | $1.88 | |||
| Day High | $47.99 | P/E | N/A | |||
| Day Low | $46.37 | EPS | $-1.12 | |||
| Volume | 160,105 | |||||



